Delivery Order SPE2DE22D0008-SPE2D624F2LS5

Award Date 7/8/24
Potential Completion Date 7/11/24
Potential Value $2.3K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60607, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Alba Bioscience, Inc., a foreign-owned for-profit organization, is for the delivery of ALBACLONE Anti-A blood typing reagents to the Defense Logistics Agency (DLA) Troop Support Medical. The $3,555.00 firm-fixed-price contract has a period of performance through June 13, 2024 and was awarded on June 10, 2024. Alba Bioscience, a subsidiary of Quotient Biodiagnostics, Inc., is a leading supplier of specialized blood banking products and services to federal...
This federal contract award, with ID SPE2DE22D0008|SPE2D624F8X8V, was issued by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization. The $6,300.00 firm fixed-price delivery order is for the supply of ALBACLONE anti-C (Big C) blood bank products. Alba Bioscience is a subsidiary of Quotient Biodiagnostics, Inc. and a leading supplier of specialized biomedical products and services, primarily supporting blood banking operations across federal...
This is a federal contract award to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various U.S. government agencies. The contract, valued at $4,886.95, is a delivery order issued by the Defense Logistics Agency Troop Support Medical for the supply of ALBACLONE Anti-S (Big S) blood bank products. The contract has a firm fixed-price pricing type and...
This federal contract award with ID SPE2DE22D0008|SPE2D625F23XA was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain to Alba Bioscience, Inc., a for-profit organization and subsidiary of Quotient Biodiagnostics, Inc. The $22,550.00 firm fixed-price contract is for the delivery of ALBACLONE Anti-D Blend products, which are specialized blood banking reagents and diagnostic materials used for blood typing and transfusion services in federal healthcare facilities. The contract...
This federal contract award was made by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various federal agencies. The contract, valued at $2,370.00, is for the delivery of ALBACLONE anti-B products. The award is not associated with a set-aside program and is a Firm Fixed Price Delivery Order contract type. Alba...
This federal contract award to Alba Bioscience, Inc., a subsidiary of Quotient Biodiagnostics, Inc., is for the delivery of ALBACLONE anti-B medical supplies. The $3,792.00 Firm Fixed Price contract was awarded on May 16, 2025 by the Defense Logistics Agency (DLA), a defense agency, with a completion date of May 21, 2025. The contract is not designated as a set-aside. Alba Bioscience, Inc. is a for-profit organization specializing in in vitro diagnostics, blood bank reagents, and other...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, and quality control materials to various U.S. government agencies. The contract, valued at $22,621.60, is a delivery order for "ALBACLONE ANTI-D BLEND" products. It is a firm fixed-price contract with a period of performance ending on...
This federal contract award, with ID SPE2DE22D0008|SPE2D625F1414, was issued by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in in vitro diagnostics, blood bank reagents, and quality control materials. The contract, with a ceiling value of $1,118.00, is for the delivery of "ALBACLONE ANTI-A" products, which are likely blood typing reagents or antibodies used in blood banking operations. The contract is a Delivery...
This federal contract award SPE2DE22D0008|SPE2D625F22W7 was issued by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization specializing in in vitro diagnostics, blood bank reagents, and quality control materials. The $5,160.00 firm fixed-price delivery order contract is for the provision of ALBACYTE antibody identification panels, a critical product supporting blood banking operations across federal healthcare systems. Alba Bioscience, a...
This federal contract award, with the ID SPE2DE22D0008|SPE2D624F7DW1, was issued by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials. The $1,906.00 firm-fixed-price contract is for the delivery of ALBACYTE antibody screening (3-cell) products, with a period of performance ending on October 8, 2024. Alba Bioscience is a...
  • SPE2DE22D0008
    Indefinite Delivery Contract
  • SPE2DE22D0008-SPE2D624F2LS5
    Delivery Order

This federal contract award, with an ID of SPE2DE22D0008|SPE2D624F2LS5, was issued by the Defense Logistics Agency Troop Support Medical to Alba Bioscience, Inc., a foreign-owned for-profit organization, for the delivery of ALBACLONE anti-LEA blood bank products. The $2,286.60 firm fixed price contract has a completion date of July 11, 2024. It is not designated as a set-aside contract.

Alba Bioscience, a subsidiary of Quotient Biodiagnostics, Inc., is a leading supplier of specialized biomedical products and services, primarily supporting blood banking operations across various federal agencies, including the Department of Veterans Affairs (VA), Defense Logistics Agency (DLA), and Department of Health and Human Services (HHS). The company holds multiple blanket purchase agreements (BPAs) with the VA through the GSA Schedule 65-VII for in vitro diagnostics, reagents, and blood bank transfusion supplies, allowing for streamlined procurement of these critical medical products.

Generated 10/7/24, 10:45 AM